The global microfluidics market is projected to reach $37.2 billion by 2030, according to a new industry outlook highlighted by ResearchAndMarkets.com. The forecast points to rising demand for point-of-care diagnostics and personalized medicine as major forces behind expected expansion across the sector.
Microfluidics technology is gaining attention because it can support faster, smaller-scale testing and analysis in healthcare and laboratory settings. The report indicates that these capabilities are helping drive adoption as medical providers and researchers look for tools that can improve efficiency, streamline workflows and support more tailored treatment approaches.
Among materials, polymers are described as the leading segment, helped by their relatively low cost and biocompatibility. On the end-user side, hospitals and diagnostic centers are expected to post the fastest growth, reflecting broader use of microfluidic systems in clinical testing and patient care.
Regionally, Asia-Pacific is forecast to deliver the strongest growth through 2030. That outlook is tied to increasing healthcare demand, continued investment in research and development, and expansion across the life sciences industry, all of which are creating a supportive environment for wider microfluidics adoption.
